HK Stock MarketDetailed Quotes

06185 CANSINOBIO

Watchlist
  • 21.150
  • +3.230+18.02%
Not Open May 2 16:08 CST
5.23BMarket Cap-3135P/E (TTM)

CANSINOBIO Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Turnover
13.65%114.28M
-66.52%345.18M
-75.17%175.63M
-96.65%21.09M
-79.86%100.55M
-76.02%1.03B
-77.08%707.4M
-69.45%629.79M
6.98%499.36M
23,086.49%4.3B
Operating income
13.65%114.28M
-66.52%345.18M
-75.17%175.63M
-96.65%21.09M
-79.86%100.55M
-76.02%1.03B
-77.08%707.4M
-69.45%629.79M
6.98%499.36M
23,086.49%4.3B
Cost of sales
----
-0.29%-1.22B
----
-154.31%-797.57M
----
6.17%-1.22B
----
49.85%-313.62M
----
-9,301.40%-1.3B
Operating expenses
29.08%-46.23M
-0.29%-1.22B
28.54%-172.72M
-154.31%-797.57M
56.10%-65.19M
6.17%-1.22B
76.91%-241.69M
49.85%-313.62M
33.73%-148.47M
-9,301.40%-1.3B
Gross profit
92.41%68.05M
-369.45%-876.02M
-99.37%2.91M
-345.59%-776.49M
-89.92%35.37M
-106.22%-186.61M
-77.16%465.71M
-77.98%316.17M
44.57%350.88M
63,231.92%3B
Selling expenses
15.27%-46.59M
-32.55%-353.4M
-29.84%-193.63M
-44.93%-128.84M
-60.25%-54.98M
-151.95%-266.61M
-132.61%-149.14M
-157.07%-88.9M
-378.52%-34.31M
-538.92%-105.82M
Administrative expenses
38.78%-37.07M
-5.89%-294.45M
11.11%-188.09M
-0.30%-140.05M
5.54%-60.55M
-19.95%-278.07M
-49.97%-211.61M
-54.35%-139.63M
-330.93%-64.1M
-179.71%-231.81M
Research and development expenses
35.40%-96.75M
18.02%-637.99M
15.92%-461.67M
-4.45%-338.37M
4.70%-149.77M
11.43%-778.26M
16.27%-549.07M
41.23%-323.97M
41.75%-157.16M
-105.08%-878.72M
Profit from asset sales
----
----
--37.46K
----
----
----
----
----
----
----
Revaluation surplus
-129.16%-2.09M
----
-379.50%-15.37M
----
56.11%7.17M
----
-82.25%5.5M
----
670.43%4.59M
----
-Changes in the fair value of other assets
-129.16%-2.09M
----
-379.50%-15.37M
----
56.11%7.17M
----
-82.25%5.5M
----
670.43%4.59M
----
Impairment and provision
-16.94%-15.05M
-71.43%-15.05M
-50.46%-801.12M
-338.13%-20.26M
-108.88%-12.87M
-381.20%-8.78M
-11,281.90%-532.45M
-6,148.65%-4.62M
-76,937.50%-6.16M
-366.50%-1.82M
-Other impairment is provision
-16.94%-15.05M
-71.43%-15.05M
-50.46%-801.12M
-338.13%-20.26M
-108.88%-12.87M
-381.20%-8.78M
-11,281.90%-532.45M
-6,148.65%-4.62M
-76,937.50%-6.16M
-366.50%-1.82M
Special items of operating profit
-230.88%-66.79M
-5.26%141.72M
44.00%167.28M
-19.13%61.58M
31.82%51.03M
16.99%149.58M
204.12%116.16M
78.83%76.15M
499.30%38.72M
4.19%127.85M
Operating profit
-6.28%-198.26M
-48.69%-2.04B
-73.96%-1.5B
-714.58%-1.34B
-242.43%-186.54M
-171.60%-1.37B
-169.67%-859.78M
-120.54%-164.8M
391.65%130.97M
576.88%1.91B
Financing income
----
-46.75%120.64M
----
-36.10%88.49M
----
184.45%226.57M
----
235.72%138.49M
----
151.10%79.65M
Financing cost
502.46%23.38M
-53.82%-64.34M
-62.52%80.29M
-92.87%-29.4M
36.14%-5.81M
23.21%-41.83M
250.27%214.19M
-125.86%-15.24M
-131.68%-9.1M
-98.09%-54.48M
Special items of earning before tax
99.98%-1.72K
----
-3,128.89%-40.7M
----
-729.24%-8.12M
----
74.07%-1.26M
----
-323.52%-979K
----
Earning before tax
12.76%-174.88M
-67.14%-1.98B
-125.10%-1.46B
-2,988.28%-1.28B
-265.82%-200.47M
-161.13%-1.18B
-150.13%-646.85M
-104.97%-41.56M
867.49%120.9M
588.30%1.94B
Tax
----
-94.78%11.45M
-99.26%1.16M
-97.98%1.16M
558.58%30.27M
838.17%219.24M
263.56%158.17M
-42.57%57.6M
---6.6M
---29.7M
After-tax profit from continuing operations
-2.75%-174.88M
-103.93%-1.97B
-197.72%-1.45B
-8,092.09%-1.28B
-248.91%-170.2M
-150.59%-964.76M
-136.64%-488.68M
-98.29%16.04M
825.59%114.3M
580.81%1.91B
Earning after tax
-2.75%-174.88M
-103.93%-1.97B
-197.72%-1.45B
-8,092.09%-1.28B
-248.91%-170.2M
-150.59%-964.76M
-136.64%-488.68M
-98.29%16.04M
825.59%114.3M
580.81%1.91B
Minority profit
84.38%-4.79M
-776.08%-484.7M
-3,192.65%-469.89M
-11,683.23%-440.74M
-330.62%-30.65M
-657.48%-55.33M
---14.27M
--3.81M
-334.55%-7.12M
---7.3M
Profit attributable to shareholders
-21.89%-170.1M
-63.04%-1.48B
-107.63%-985.03M
-6,975.54%-841.43M
-214.94%-139.55M
-147.51%-909.43M
-135.57%-474.41M
-98.69%12.24M
960.23%121.41M
582.65%1.91B
Basic earnings per share
-21.05%-0.69
-63.32%-6.01
-107.81%-3.99
-6,920.00%-3.41
-216.33%-0.57
-147.55%-3.68
-135.62%-1.92
-98.68%0.05
916.67%0.49
550.00%7.74
Diluted earnings per share
-21.05%-0.69
-63.32%-6.01
-107.81%-3.99
-6,920.00%-3.41
-216.33%-0.57
-147.55%-3.68
-135.62%-1.92
-98.68%0.05
916.67%0.49
550.00%7.74
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
HKAS
CAS (2007)
HKAS
CAS (2007)
HKAS
CAS (2007)
HKAS
CAS (2007)
HKAS
Audit Opinions
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
--
Deloitte & Touche Tohmatsu, Deloitte Touche Tohmatsu (Special General Partnership)
--
--
--
Deloitte & Touche Tohmatsu, Deloitte Touche Tohmatsu (Special General Partnership)
--
--
--
Deloitte & Touche Tohmatsu, Deloitte Touche Tohmatsu (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Turnover 13.65%114.28M-66.52%345.18M-75.17%175.63M-96.65%21.09M-79.86%100.55M-76.02%1.03B-77.08%707.4M-69.45%629.79M6.98%499.36M23,086.49%4.3B
Operating income 13.65%114.28M-66.52%345.18M-75.17%175.63M-96.65%21.09M-79.86%100.55M-76.02%1.03B-77.08%707.4M-69.45%629.79M6.98%499.36M23,086.49%4.3B
Cost of sales -----0.29%-1.22B-----154.31%-797.57M----6.17%-1.22B----49.85%-313.62M-----9,301.40%-1.3B
Operating expenses 29.08%-46.23M-0.29%-1.22B28.54%-172.72M-154.31%-797.57M56.10%-65.19M6.17%-1.22B76.91%-241.69M49.85%-313.62M33.73%-148.47M-9,301.40%-1.3B
Gross profit 92.41%68.05M-369.45%-876.02M-99.37%2.91M-345.59%-776.49M-89.92%35.37M-106.22%-186.61M-77.16%465.71M-77.98%316.17M44.57%350.88M63,231.92%3B
Selling expenses 15.27%-46.59M-32.55%-353.4M-29.84%-193.63M-44.93%-128.84M-60.25%-54.98M-151.95%-266.61M-132.61%-149.14M-157.07%-88.9M-378.52%-34.31M-538.92%-105.82M
Administrative expenses 38.78%-37.07M-5.89%-294.45M11.11%-188.09M-0.30%-140.05M5.54%-60.55M-19.95%-278.07M-49.97%-211.61M-54.35%-139.63M-330.93%-64.1M-179.71%-231.81M
Research and development expenses 35.40%-96.75M18.02%-637.99M15.92%-461.67M-4.45%-338.37M4.70%-149.77M11.43%-778.26M16.27%-549.07M41.23%-323.97M41.75%-157.16M-105.08%-878.72M
Profit from asset sales ----------37.46K----------------------------
Revaluation surplus -129.16%-2.09M-----379.50%-15.37M----56.11%7.17M-----82.25%5.5M----670.43%4.59M----
-Changes in the fair value of other assets -129.16%-2.09M-----379.50%-15.37M----56.11%7.17M-----82.25%5.5M----670.43%4.59M----
Impairment and provision -16.94%-15.05M-71.43%-15.05M-50.46%-801.12M-338.13%-20.26M-108.88%-12.87M-381.20%-8.78M-11,281.90%-532.45M-6,148.65%-4.62M-76,937.50%-6.16M-366.50%-1.82M
-Other impairment is provision -16.94%-15.05M-71.43%-15.05M-50.46%-801.12M-338.13%-20.26M-108.88%-12.87M-381.20%-8.78M-11,281.90%-532.45M-6,148.65%-4.62M-76,937.50%-6.16M-366.50%-1.82M
Special items of operating profit -230.88%-66.79M-5.26%141.72M44.00%167.28M-19.13%61.58M31.82%51.03M16.99%149.58M204.12%116.16M78.83%76.15M499.30%38.72M4.19%127.85M
Operating profit -6.28%-198.26M-48.69%-2.04B-73.96%-1.5B-714.58%-1.34B-242.43%-186.54M-171.60%-1.37B-169.67%-859.78M-120.54%-164.8M391.65%130.97M576.88%1.91B
Financing income -----46.75%120.64M-----36.10%88.49M----184.45%226.57M----235.72%138.49M----151.10%79.65M
Financing cost 502.46%23.38M-53.82%-64.34M-62.52%80.29M-92.87%-29.4M36.14%-5.81M23.21%-41.83M250.27%214.19M-125.86%-15.24M-131.68%-9.1M-98.09%-54.48M
Special items of earning before tax 99.98%-1.72K-----3,128.89%-40.7M-----729.24%-8.12M----74.07%-1.26M-----323.52%-979K----
Earning before tax 12.76%-174.88M-67.14%-1.98B-125.10%-1.46B-2,988.28%-1.28B-265.82%-200.47M-161.13%-1.18B-150.13%-646.85M-104.97%-41.56M867.49%120.9M588.30%1.94B
Tax -----94.78%11.45M-99.26%1.16M-97.98%1.16M558.58%30.27M838.17%219.24M263.56%158.17M-42.57%57.6M---6.6M---29.7M
After-tax profit from continuing operations -2.75%-174.88M-103.93%-1.97B-197.72%-1.45B-8,092.09%-1.28B-248.91%-170.2M-150.59%-964.76M-136.64%-488.68M-98.29%16.04M825.59%114.3M580.81%1.91B
Earning after tax -2.75%-174.88M-103.93%-1.97B-197.72%-1.45B-8,092.09%-1.28B-248.91%-170.2M-150.59%-964.76M-136.64%-488.68M-98.29%16.04M825.59%114.3M580.81%1.91B
Minority profit 84.38%-4.79M-776.08%-484.7M-3,192.65%-469.89M-11,683.23%-440.74M-330.62%-30.65M-657.48%-55.33M---14.27M--3.81M-334.55%-7.12M---7.3M
Profit attributable to shareholders -21.89%-170.1M-63.04%-1.48B-107.63%-985.03M-6,975.54%-841.43M-214.94%-139.55M-147.51%-909.43M-135.57%-474.41M-98.69%12.24M960.23%121.41M582.65%1.91B
Basic earnings per share -21.05%-0.69-63.32%-6.01-107.81%-3.99-6,920.00%-3.41-216.33%-0.57-147.55%-3.68-135.62%-1.92-98.68%0.05916.67%0.49550.00%7.74
Diluted earnings per share -21.05%-0.69-63.32%-6.01-107.81%-3.99-6,920.00%-3.41-216.33%-0.57-147.55%-3.68-135.62%-1.92-98.68%0.05916.67%0.49550.00%7.74
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)HKASCAS (2007)HKASCAS (2007)HKASCAS (2007)HKASCAS (2007)HKAS
Audit Opinions --Unqualified Opinion------Unqualified Opinion------Unqualified Opinion
Auditor --Deloitte & Touche Tohmatsu, Deloitte Touche Tohmatsu (Special General Partnership)------Deloitte & Touche Tohmatsu, Deloitte Touche Tohmatsu (Special General Partnership)------Deloitte & Touche Tohmatsu, Deloitte Touche Tohmatsu (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg